Pancreatic cancer is a type of cancer that forms in certain cells of the pancreas. Most patients with pancreatic cancer (about 95%) start in the exocrine pancreas. Tumors can also form in the endocrine pancreas, but these are uncommon and are usually benign (not cancerous).

Pancreatic carcinoma (PDAC) is one of the most difficult malignancies to treat. Individual patient and tumor factors need to be taken into account to provide an optimal, individualized approach. In this article, biomarkers for pancreatic cancer prognosis and some can be used to guide treatment decisions.